Answer
Tafinlar (dabrafenib mesilate) with trametinib is indicated as adjuvant treatment for adults with Stage III melanoma with a BRAF V600 mutation following complete resection.
Sources for this answer
- Tafinlar 50 mg & 75 mg hard capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 40Document updated
Sources checked